Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor
Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
Author

Stephen Riddle

Stephen Riddle

Stephen is a top-notch and professional content writer at TopPharmaNews.com. He primarily focuses on news related to the Pharma News Field, particularly the groundbreaking discoveries taking place in the sector. It includes various clinical researches, findings, along with some happenings in the Pharma field. Additionally, he is an editorial assistant at the site. Thus, he keeps track of the news being published on TopPharmaNews.com.

  • Pharma News

    Ipsen’s Cabometyx recommended by NICE for previously treated HCC

    by Stephen Riddle November 10, 2022
    by Stephen Riddle November 10, 2022

    French drugmaker Ipsen’s Cabometyx (cabozantinib) has been recommended by the National Institute for Health and…

    Read more
  • Pharma News

    UK digital health firms join together on stroke care platform

    by Stephen Riddle November 10, 2022
    by Stephen Riddle November 10, 2022

    A partnership between two UK digital health companies – Brainomix and Visionable – aims to…

    Read more
  • Pharma News

    Clovis warns of insolvency as Rubraca goes into reverse

    by Stephen Riddle November 10, 2022
    by Stephen Riddle November 10, 2022

    Clovis Oncology has said it may not have enough cash to fund continuing operations beyond…

    Read more
  • Pharma News

    Nordic Nanovector to merge with APIM after Betalutin fail

    by Stephen Riddle November 10, 2022
    by Stephen Riddle November 10, 2022

    Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector…

    Read more
  • Pharma News

    ‘Healthcare shouldn’t be about treatment’: are diagnostics the answer to ending disease and virus outbreaks?

    by Stephen Riddle November 10, 2022
    by Stephen Riddle November 10, 2022

    In a perfect world, everyone would have equal access to healthcare. The health services some…

    Read more
  • Pharma News

    The power of patient perspectives in the publication of real-world studies

    by Stephen Riddle November 9, 2022
    by Stephen Riddle November 9, 2022

    Patients have a unique first-hand insight into their condition, which can be a valuable asset…

    Read more
  • Pharma News

    FDA panel backs AZ’s PT027 asthma rescue drug, but in adults only

    by Stephen Riddle November 9, 2022
    by Stephen Riddle November 9, 2022

    AstraZeneca has moved a step closer to bringing a first-in-class drug to market in the…

    Read more
  • Pharma News

    NRG announces £16m Series A for IND for Parkinson’s and ALS

    by Stephen Riddle November 9, 2022
    by Stephen Riddle November 9, 2022

    A £16 million Series A financing – led by Omega Funds – has been announced…

    Read more
  • Pharma News

    Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part i)

    by Stephen Riddle November 9, 2022
    by Stephen Riddle November 9, 2022

    It goes without saying that The Economist’s 8th Annual World Cancer Series congress was well-attended…

    Read more
  • Pharma News

    FDA blocks early filing for ADC drug, signalling tougher stance

    by Stephen Riddle November 9, 2022
    by Stephen Riddle November 9, 2022

    ADC Therapeutics has said it will not seek accelerated approval of its Hodgkin lymphoma drug…

    Read more
  • Pharma News

    GSK plans phase 3 for hepatitis B drug bepirovirsen, despite efficacy drop

    by Stephen Riddle November 9, 2022
    by Stephen Riddle November 9, 2022

    GSK has revealed updated results from its phase 2b trial of its antisense drug for…

    Read more
  • Pharma News

    Sanofi signs $1.2bn research alliance with AI specialist Insilico

    by Stephen Riddle November 9, 2022
    by Stephen Riddle November 9, 2022

    Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a…

    Read more
  • Pharma News

    Capturing progress in haemophilia care

    by Stephen Riddle November 9, 2022
    by Stephen Riddle November 9, 2022

    If we look back just 70 years, the prognosis for patients with haemophilia was remarkably…

    Read more
  • Pharma News

    Respiri recruits first patients in US wheezo programme

    by Stephen Riddle November 8, 2022
    by Stephen Riddle November 8, 2022

    Australian digital health Respiri has started to roll out its digital remote patient monitoring (RPM)…

    Read more
  • Pharma News

    NICE backs use of MSD’s KEYTRUDA for triple-negative breast cancer

    by Stephen Riddle November 8, 2022
    by Stephen Riddle November 8, 2022

    For the first time, patients in England with triple-negative breast cancer (TNBC) will be able…

    Read more
  • Pharma News

    J&J, Idorsia plan filings for aprocitentan data in resistant hypertension

    by Stephen Riddle November 8, 2022
    by Stephen Riddle November 8, 2022

    People whose blood pressure remains stubbornly high despite current drug treatment and are at increased…

    Read more
  • Pharma News

    Lilly preps for rollout of its connected diabetes system

    by Stephen Riddle November 8, 2022
    by Stephen Riddle November 8, 2022

    After years of preparation, Eli Lilly is on the brink of launching a fully connected…

    Read more
  • Pharma News

    Pandemic boost to decentralised trials is here to stay

    by Stephen Riddle November 8, 2022
    by Stephen Riddle November 8, 2022

    Due to the pandemic, decentralised trial solutions made the shift from an emerging trend to…

    Read more
  • Pharma News

    Why real patient centricity is more essential than ever before

    by Stephen Riddle November 8, 2022
    by Stephen Riddle November 8, 2022

    Ask nearly any pharma company these days if they’re patient-centric, and you’ll probably get an…

    Read more
  • Pharma News

    Chasing Novartis, Amgen ushers Lp(a) drug into phase 3

    by Stephen Riddle November 7, 2022
    by Stephen Riddle November 7, 2022

    Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a…

    Read more
  • Pharma News

    GSK’s Blenrep hopes take a knock as drug fails trial

    by Stephen Riddle November 7, 2022
    by Stephen Riddle November 7, 2022

    GSK has great expectations for its BCMA-directed cancer drug Blenrep, but a failed phase 3…

    Read more
  • Pharma News

    6th Obesity & NASH Drug Development Summit 2022

    by Stephen Riddle November 7, 2022
    by Stephen Riddle November 7, 2022

    While investment in NASH has waned in the context of rigid histological endpoints and clinical…

    Read more
  • Pharma News

    Chairs from Aerie Pharmaceuticals & Santen Inc Invitation to join Ophthalmic Drugs

    by Stephen Riddle November 7, 2022
    by Stephen Riddle November 7, 2022

    SAE Media Group reports: Mitchell de Long, Vice President, Chemistry from Aerie Pharmaceuticals and Naj…

    Read more
  • Pharma News

    The ins and outs of the life sciences: top hires for October 2022 

    by Stephen Riddle November 7, 2022
    by Stephen Riddle November 7, 2022

    In this new segment from pharmaphorum, we collect the most significant hirings, firings, and recruitment…

    Read more
  • Pharma News

    NICE backs digital CBT apps for youngsters with anxiety

    by Stephen Riddle November 7, 2022
    by Stephen Riddle November 7, 2022

    Draft guidance in the UK has provisionally recommended that digital cognitive behavioural therapy (CBT) apps…

    Read more
  • Pharma News

    First human trials of lab-grown red blood cells start in UK

    by Stephen Riddle November 7, 2022
    by Stephen Riddle November 7, 2022

    Blood cells grown in a laboratory have been given to people for the first time…

    Read more
  • Pharma News

    Artificial Intelligence for better antibody drugs: ready for prime time?

    by Stephen Riddle November 7, 2022
    by Stephen Riddle November 7, 2022

    The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is…

    Read more
  • Pharma News

    Planning appeal blocks Lilly’s €400m plant in Ireland

    by Stephen Riddle November 6, 2022
    by Stephen Riddle November 6, 2022

    Eli Lilly plans for a new biopharmaceutical manufacturing facility in Ireland that will be used…

    Read more
  • Pharma News

    AZ, Sanofi get first green light for RSV prophylactic antibody

    by Stephen Riddle November 6, 2022
    by Stephen Riddle November 6, 2022

    AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug…

    Read more
  • Pharma News

    Unlocking the full power of data for Pharma

    by Stephen Riddle November 4, 2022
    by Stephen Riddle November 4, 2022

    The value of data has never been greater in healthcare. With greater digital engagement and…

    Read more
  • Pharma News

    Pfizer/BioNTech begin phase 1 of COVID-19/influenza combo

    by Stephen Riddle November 4, 2022
    by Stephen Riddle November 4, 2022

    BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate…

    Read more
  • Pharma News

    Galapagos’ new CEO Paul Stoffels wields axe in bid to go ‘forward, faster’

    by Stephen Riddle November 4, 2022
    by Stephen Riddle November 4, 2022

    When long-serving Johnson & Johnson R&D chief Paul Stoffels cut short his retirement to take…

    Read more
  • Pharma News

    Boehringer recruits former Novartis’ neurosciences head as its CMO

    by Stephen Riddle November 4, 2022
    by Stephen Riddle November 4, 2022

    Boehringer Ingelheim has appointed Lykke Hinsch Gylvin as its new head of medicine and chief…

    Read more
  • Pharma News

    Why blockchain is big pharma’s big focus

    by Stephen Riddle November 4, 2022
    by Stephen Riddle November 4, 2022

    To address the supply chain vulnerabilities of the pharma industry, an innovative, collaborative blockchain-based system…

    Read more
  • Pharma News

    NGOs claim UK-India free trade deal will raise medicine prices

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    Consumer and health organisations in the UK have written to the Trade Secretary Kemi Badenoch,…

    Read more
  • Pharma News

    And then there were none: Regeneron cans last late-stage NGF drug

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    The hope that nerve growth factor (NGF) inhibitors could be an alternative to opioid for…

    Read more
  • Pharma News

    GSK preps filing for novel antibiotic for urinary tract infections

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    In an encouraging development for the fight against antimicrobial resistance (AMR), GSK’s novel antibiotic gepotidacin…

    Read more
  • Pharma News

    Alkermes may separate oncology business, says CEO

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    Alkermes has said it is considering a spin-out of its cancer business into an independent,…

    Read more
  • Pharma News

    Health Innovators – Matthew Holt

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    At Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sat down with Matthew Holt,…

    Read more
  • Pharma News

    The pharmaphorum podcast: Why is digital health so challenging for big tech?

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    In this episode of the pharmaphorum podcast, host Jonah Comstock taps XIL Health’s Susan Lang…

    Read more
  • Pharma News

    Largest-ever trial backs psilocybin treatment for depression

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    The psychedelic compound in magic mushrooms – psilocybin – can improve the symptoms of severe…

    Read more
  • Pharma News

    How pharma can thrive in the digital era

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    December marks the one year anniversary of the U.S. Food and Drug Administration’s (FDA) draft…

    Read more
  • Pharma News

    Anthropy 2022 – Day Two

    by Stephen Riddle November 3, 2022
    by Stephen Riddle November 3, 2022

    Thursday 3rd November marks the second day of Anthropy 2022 at the Eden Project on…

    Read more
  • Pharma News

    Pharmacy chains agree $10bn settlement in opioid litigation

    by Stephen Riddle November 2, 2022
    by Stephen Riddle November 2, 2022

    CVS Health and Walgreens have become the first two US pharmacy chains to agree a…

    Read more
  • Pharma News

    J&J bulks up before consumer health spinout with Abiomed buy

    by Stephen Riddle November 2, 2022
    by Stephen Riddle November 2, 2022

    Johnson & Johnson’s $16.6 billion takeover offer for cardiac pump manufacturer Abiomed looks set to…

    Read more
  • Pharma News

    After Haleon spinoff, GSK raises forecasts on ‘strong’ Q3

    by Stephen Riddle November 2, 2022
    by Stephen Riddle November 2, 2022

    In its first set of quarterly results since it separated from its consumer health business,…

    Read more
  • Pharma News

    CSL makes $4bn+ move in mRNA vaccines with Arcturus deal

    by Stephen Riddle November 2, 2022
    by Stephen Riddle November 2, 2022

    Australia’s CSL is the latest vaccines company to buy into the mRNA category, tapping US…

    Read more
  • Pharma News

    Lilly says Mounjaro launch is “viral in nature”

    by Stephen Riddle November 2, 2022
    by Stephen Riddle November 2, 2022

    One of the highlights of Eli Lilly’s third-quarter results was the rapid uptake of new…

    Read more
  • Pharma News

    Anthropy 2022 – Day One

    by Stephen Riddle November 2, 2022
    by Stephen Riddle November 2, 2022

    Wednesday 2nd November heralds the start of Anthropy 2022 at The Eden Project. With pharmaphorum…

    Read more
  • Pharma News

    Norstella, Citeline merge to create $5bn pharma tech firm

    by Stephen Riddle November 2, 2022
    by Stephen Riddle November 2, 2022

    Citeline and Norstella have completed a merger, first announced in June, to create one of…

    Read more
  • 1
  • 2
  • 3
  • …
  • 34

Recent Posts

  • Ipsen’s Cabometyx recommended by NICE for previously treated HCC

    November 10, 2022
  • UK digital health firms join together on stroke care platform

    November 10, 2022
  • Clovis warns of insolvency as Rubraca goes into reverse

    November 10, 2022
  • Nordic Nanovector to merge with APIM after Betalutin fail

    November 10, 2022
  • ‘Healthcare shouldn’t be about treatment’: are diagnostics the answer to ending disease and virus outbreaks?

    November 10, 2022
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor

@2018 - TopPharmaNews.com. All Right Reserved.